Samlyn Capital’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-730,744
Closed -$48.1M 114
2023
Q3
$48.1M Sell
730,744
-258,817
-26% -$19.3M 0.79% 42
2023
Q2
$80.5M Buy
+989,561
New +$70.4M 1.36% 29
2023
Q1
Sell
-425,675
Closed -$20.8M 114
2022
Q4
$20.8M Sell
425,675
-2,385,639
-85% -$110M 0.41% 57
2022
Q3
$145M Buy
2,811,314
+1,378,162
+96% +$81.8M 2.7% 8
2022
Q2
$75.3M Buy
1,433,152
+1,016,357
+244% +$70.7M 1.51% 20
2022
Q1
$35.8M Buy
+416,795
New +$34.2M 0.52% 55
2015
Q1
Sell
-195,400
Closed -$9.9M 105
2014
Q4
$9.9M Buy
+195,400
New +$10.2M 0.17% 92
2013
Q4
Sell
-2,339,484
Closed -$96.4M 108
2013
Q3
$96.4M Buy
2,339,484
+200,604
+9% +$8.39M 2.69% 2
2013
Q2
$98.6M Buy
+2,138,880
New +$95.8M 2.88% 2

Other funds holding THC

Samlyn Capital's THC Position: Q4 2023 in Review

Samlyn Capital sold out of Tenet Healthcare (THC) in Q4 2023, closing a stake of 730,744 shares — an estimated $48.1M sold.

Samlyn Capital first reported a position in THC in Q2 2013 and held it in 9 quarters. The position peaked at $145M in Q3 2022. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.

  • Samlyn Capital reported no remaining Tenet Healthcare position as of Q4 2023 after selling out during the quarter.
  • Samlyn Capital sold 730,744 Tenet Healthcare shares in Q4 2023, an estimated $48.1M.
  • Samlyn Capital first reported a position in Tenet Healthcare in Q2 2013 and held it in 9 quarters.
  • Samlyn Capital's Tenet Healthcare position peaked at $145M in Q3 2022.
  • 425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.

Based on Samlyn Capital's 13F filing for Q4 2023, filed 14 Feb 2024.